Cubist Systematic Strategies’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
135,656
+88,684
| +189% | +$978K | 0.01% | 796 |
|
|
2025
Q1 | $419K | Buy |
+46,972
| New | +$419K | ﹤0.01% | 1051 |
|
|
2024
Q2 | – | Sell |
-5,834
| Closed | -$52.3K | – | 2542 |
|
|
2024
Q1 | $52.3K | Buy |
+5,834
| New | +$52.3K | ﹤0.01% | 1912 |
|
|
2023
Q1 | – | Sell |
-151,440
| Closed | -$1.7M | – | 3257 |
|
|
2022
Q4 | $1.7M | Buy |
151,440
+37,573
| +33% | +$422K | 0.01% | 1410 |
|
|
2022
Q3 | $1.16M | Buy |
113,867
+23,298
| +26% | +$236K | 0.01% | 1970 |
|
|
2022
Q2 | $821K | Sell |
90,569
-63,916
| -41% | -$579K | 0.01% | 2249 |
|
|
2022
Q1 | $1.48M | Buy |
154,485
+70,663
| +84% | +$676K | 0.01% | 1730 |
|
|
2021
Q4 | $926K | Buy |
83,822
+57,738
| +221% | +$638K | 0.01% | 1972 |
|
|
2021
Q3 | $193K | Buy |
+26,084
| New | +$193K | ﹤0.01% | 2598 |
|
|
2021
Q1 | – | Sell |
-10,689
| Closed | -$190K | – | 2972 |
|
|
2020
Q4 | $190K | Buy |
+10,689
| New | +$190K | ﹤0.01% | 2258 |
|
|
2020
Q3 | – | Sell |
-30,751
| Closed | -$645K | – | 2635 |
|
|
2020
Q2 | $645K | Buy |
+30,751
| New | +$645K | 0.01% | 1448 |
|
|
2020
Q1 | – | Sell |
-27,809
| Closed | -$720K | – | 2447 |
|
|
2019
Q4 | $720K | Buy |
+27,809
| New | +$720K | 0.01% | 1361 |
|
|
2019
Q3 | – | Sell |
-28,969
| Closed | -$473K | – | 2472 |
|
|
2019
Q2 | $473K | Buy |
28,969
+15,627
| +117% | +$255K | 0.01% | 1512 |
|
|
2019
Q1 | $302K | Buy |
13,342
+5,484
| +70% | +$124K | 0.01% | 1493 |
|
|
2018
Q4 | $201K | Buy |
+7,858
| New | +$201K | 0.01% | 1539 |
|
|
2017
Q1 | – | Sell |
-931
| Closed | -$30K | – | 1856 |
|
|
2016
Q4 | $30K | Buy |
+931
| New | +$30K | ﹤0.01% | 1614 |
|